Patel discusses the healthcare company's transformation and the work of IT to achieve the organization’s goals.

Baxter International stock hits 20-year low, but undervaluation and new CEO strategy offer turnaround potential.

Healthcare company Baxter International (NYSE:BAX) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 5% ...

Baxter International Inc (($BAX)) has held its Q3 earnings call. Read on for the main highlights of the call. Baxter ...

As Baxter International has underperformed the broader market over the past year, Wall Street analysts maintain a cautious ...

Baxter EVP and Chief Operating Officer Heather Knight is leaving to become chief commercial officer at Solventum.

Q3 2025 Management View Andrew Hider, President, Chief Executive Officer, addressed his first earnings call, emphasizing both the foundational strengths and the urgent need for improvement at Baxter.

On a revised dealmaking spree this year, Korea’s Samsung Biologics is re-tooling its long-running drug manufacturing pact with Baxter Healthcare. The retooled deal, first established back in July of ...

Baxter (NYSE: BAX) shares took a hit today on third-quarter results that failed to meet the consensus sales forecast on Wall ...

Five new launches reinforce Baxter’s focus on differentiated products and enhance the company’s Pharmaceuticals portfolio in critical therapeutic areas Products feature ready-to-use formulations to ...

Baxter International on Thursday trimmed its forecasts for adjusted annual profit and revenue growth, after missing third-quarter revenue estimates due to persistent impact from hurricane-related ...

The storm tested every system and every person—revealing the true power of maintenance and reliability leadership under ...